Journal of Medicinal Chemistry · 1988 · 43 citations · 0 references
Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryAntitumor ActivityBiochemistryBenzimidazole RingNatural SciencesMedicineHeterocyclicOrganic ChemistryAnti-cancer AgentPotential Antitumor ActivityHeterocycle ChemistryPharmacologyP388 LeukemiaBenzimidazole-4,7-dione DerivativesDrug Discovery
A series of benzimidazole-4,7-dione derivatives, bearing substituents at positions 1, 2, 5, and 6 of the benzimidazole ring, has been synthesized and tested for antitumor activity in vivo on P388 leukemia. Some of the synthesized compounds show significant antitumor activity, associated with high toxicity, however. Compounds 7, 18, and 27 show the highest antitumor activity in this series, whereas 17, 19, and 22 are scarcely active. Some hypothetical biological precursors of these quinones are devoid of antitumor activity. Some structure-activity relationships are discussed.